News

/News/

Triumvira Immunologics Announces Fast Track Designation for Its First TAC T-Cell Therapeutic Product Candidate: TAC01-CD19

By | November 7th, 2019|Bloom Burton, Clinical Trial Update, News|

Triumvira Immunologics Announces Fast Track Designation for Its First TAC [...]

MindBeacon Group announces Series A follow-on investment round led by Green Shield Canada has exceeded $18 million

By | November 5th, 2019|Bloom Burton, Financing, News|

MindBeacon Group announces Series A follow-on investment round led by [...]

Medicenna Announces Closing of Public Offering of $6,900,000

By | October 17th, 2019|Bloom Burton, Financing, News|

Medicenna Announces Closing of Public Offering of $6,900,000 Original press [...]

Poul Sorensen Receives the 2019 Bloom Burton Award

By | September 30th, 2019|Uncategorized|

Poul Sorensen Receives the 2019 Bloom Burton Award September 30, [...]

BELLUS Health Closes US$70 Million Public Offering of Common Shares in Canada and the United States

By | September 9th, 2019|Bloom Burton, Financing, News|

BELLUS Health Closes US$70 Million Public Offering of Common Shares [...]

Q2 2019 Share Price Performance

By | August 30th, 2019|Analysis, Blog, Capital Markets|

Analysis: Healthcare Stocks Slide In this blog post, the Bloom [...]

ESSA Pharma Completes Public Offering and Concurrent Private Placement for Aggregate Gross Proceeds of US$36 Million

By | August 27th, 2019|Bloom Burton, Financing, News|

ESSA PHARMA COMPLETES PUBLIC OFFERING AND CONCURRENT PRIVATE PLACEMENT FOR [...]

Antibe Announces Closing of Public Offering

By | August 13th, 2019|Bloom Burton, Financing, News|

Antibe Announces Closing of Public Offering Original press release here [...]

Canada in Science – June 10, 2019

By | June 10th, 2019|Blog, Canada in Science|

Welcome to your Canada in Science Review for June 10th, [...]

Resverlogix Announces Closing of $15 Million Offering

By | June 7th, 2019|Financing, News|

Resverlogix Announces Closing of $15 Million Offering NOT FOR DISTRIBUTION [...]